Skip to main content
Smart Investors Daily
Putnam BioRevolution ETF logo

AMEX · SYNB

Putnam BioRevolution ETF

Financial Services · Asset Management

$31.61

Down-$0.12 (-0.37%)

Updated Aug 31, 2026, 9:38 PM

SID Score

4.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
5.29M
P/E ratio
Dividend yield
0.00%
52-week range
$24.57 – $31.73
Volume
449
Avg. volume
850

Price performance

SYNB price history

1M range · 0 trading sessions · Daily adjusted prices

SYNB does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SYNB news

The latest Smart Investors Daily articles mentioning SYNB.

SYNB research

Overview

Company profile and research snapshot.

Company profile

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

businesswire.com · Sep 19, 2025

Franklin Templeton Announces Plan to Liquidate Putnam BioRevolution™ ETF

SAN MATEO, Calif.--(BUSINESS WIRE)--Franklin Templeton today announced it will liquidate and dissolve Putnam BioRevolution™ ETF (SYNB). The liquidation is anticipated to occur on or about November 21, 2025, although the Fund may make dispositions of portfolio holdings prior to the liquidation date. Effective as of the close of business on October 24, 2025, the Fund will no longer accept orders for the purchase of creation units, and effective as of the close of business on November 13, 2025, th.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.